ClinicalTrials.gg
Sign In

EyeBiotech Ltd. clinical trials

Acquired by Merck & Co., Inc, Jul 2024 · source ↗

The registry lists 7 studies whose lead sponsor is EyeBiotech Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Before and after it joined Merck & Co., Inc

First submitted before EyeBiotech Ltd. became part of Merck & Co., Inc
1
First submitted after EyeBiotech Ltd. became part of Merck & Co., Inc
6
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs EyeBiotech Ltd.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of EyeBiotech Ltd.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 7 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now343%
  • Under way, not recruiting229%
  • Completed229%

Phase

  • Phase 27
  • Phase 34
  • Phase 12

Where

  • United States7
  • Puerto Rico5
  • Argentina4
  • United Kingdom3
  • Spain3
  • Colombia3

Over the years

  1. 23
  2. 224
  3. 25
  4. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • EyeBiotech Ltd.7 studies

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 7 of 7. All Merck & Co., Inc studies →